Skip to main content
Premium Trial:

Request an Annual Quote

Compaq Presents Four-Way Server To Enterprise Market


HOUSTON--Compaq Computer announced this month that it will begin offering its AlphaServers running Tru64 Unix to enterprise markets such as high-performance technical computing. The company also released new Tru64 Unix and TruCluster software, and what it claimed is the industry's fastest four-way RISC server, the AlphaServer ES40. Compaq said it intends to make Linux/Tru64 applications and products compatible.

Celera Genomics, of Rockville, Md., which is building a powerful bioinformatics computing facility, has installed Compaq AlphaServer ES40s with Tru64 Unix as the building blocks that will allow it to deliver genomics data quickly, according to Marshall Peterson, Celera's director of technology and infrastructure. The servers' "computational performance and 64-bit architecture play a key role in our plan to map the human genome," Peterson said.

Compaq's AlphaServer with one 500MHz Alpha 21264 CPU, 512 MB RAM, 4 GB disk, and 4 MB cache will be available in May for under $23,900. The TruCluster Server v.5.0 and the Tru64 Unix v.5.0 will be available in the summer, starting at $5,000 and $2,500, respectively.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.